BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 400421)

  • 1. Reduction of experimental myocardial infarct size by combined treatment with methylprednisolone sodium succinate and betahistine hydrochloride.
    Joyce LD; Smith JM; Mauer HG; Lillehei RC
    Adv Shock Res; 1978; 1():235-49. PubMed ID: 400421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal factors in the reduction of myocardial infarct volume by methylprednisolone.
    Shatney CH; MacCarter DJ; Lillehei RC
    Surgery; 1976 Jul; 80(1):61-9. PubMed ID: 1273768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of megadose methylprednisolone on experimental myocardial infarct size.
    Shatney CH; Lillehei RC
    Adv Shock Res; 1982; 8():187-93. PubMed ID: 7136944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.
    Vogel WM; Zannoni VG; Abrams GD; Lucchesi BR
    Circulation; 1977 Apr; 55(4):588-95. PubMed ID: 837501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
    Maroko PR; Carpenter CB; Chiariello M; Fishbein MC; Radvany P; Knostman JD; Hale SL
    J Clin Invest; 1978 Mar; 61(3):661-70. PubMed ID: 641147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of canrenoate potassium (aldactone pro injections) on hemodynamics and myocardial ischemia in experimental myocardial infarct].
    Kötter V; Leitner Ev; Arbeiter G; Cordes R; Schröder R
    Z Kardiol; 1975 Jul; 64(7):672-86. PubMed ID: 1163092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left atrium-to-femoral artery bypass: effectiveness in reduction of acute experimental myocardial infarction.
    Catinella FP; Cunningham JN; Glassman E; Laschinger JC; Baumann FG; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Dec; 86(6):887-96. PubMed ID: 6645591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of myocardial infarct size in rats under the effect of bepridil.
    Richard V; de Leiris J
    Adv Myocardiol; 1985; 6():563-72. PubMed ID: 3873103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the effectiveness of methylprednisolone sodium succinate in reducing the infarct area].
    Tartagni F; Melandri G; Maresta A; Magnani B
    Boll Soc Ital Cardiol; 1981; 26(10):939-48. PubMed ID: 6758813
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of intra-aortic balloon pumping to reduce experimental myocardial infarct size in swine.
    Laas J; Campbell CD; Takanashi Y; Pick RL; Replogle RL
    J Thorac Cardiovasc Surg; 1980 Jul; 80(1):85-93. PubMed ID: 7382539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylprednisolone as an intervention following myocardial infarction. The Solu-Medrol Sterile Powder AMI Studies Group.
    J Int Med Res; 1986; 14 Suppl 1():1-10. PubMed ID: 2875003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hydrocortisone on the hemodynamics and serum CK and MBCK enzymes in acute myocardial infarct in dogs.
    Prasad K; Kim RB; Debnath D
    Can J Cardiol; 1986; 2(1):34-41. PubMed ID: 3633749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seventy-two hour comparison of methylprednisolone suleptanate and methylprednisolone sodium succinate in patients with acute asthma.
    Muir JF; Godard PH; Verhaert ; Leophonte P; Racineux JL; Harry JD
    Br J Clin Pract; 1996 Dec; 50(8):440-5. PubMed ID: 9039715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylprednisolone sodium succinate in acute myocardial infarct].
    Tartagni F; Melandri G; Maresta A; Magnani B
    Minerva Cardioangiol; 1983 Dec; 31(12):733-40. PubMed ID: 6366613
    [No Abstract]   [Full Text] [Related]  

  • 17. Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog.
    Kingma JG; Denniss AR; Hearse DJ; Downey JM; Yellon DM
    Circulation; 1987 Jun; 75(6 Pt 2):V25-33. PubMed ID: 3568337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inability of fructose 1,6-diphosphate to reduce myocardial infarct size.
    Brown EJ; Erburu L; Kloner RA
    J Med; 1987; 18(1):43-53. PubMed ID: 3474341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylprednisolone sodium succinate on clearance of live E coli from the peripheral blood of dogs.
    White GL; Archer LT; Elmore OF; Hinshaw LB
    Adv Shock Res; 1979; 2():233-44. PubMed ID: 400578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental myocardial infarction in rhesus monkeys. Verapamil pretreatment in the reduction of infarct size.
    Anand IS; Sharma PL; Chakravarti RN; Wahi PL
    Adv Myocardiol; 1980; 2():425-33. PubMed ID: 7423056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.